JODY GILCHRIST: Open Payments
NPI 1649407420 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 80 payments from 16 companies in 2025. Trend: 2023 $1,267 · 2024 $1,751 · 2025 $1,575
Food & beverage: $1,575
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $304 |
| E.R. Squibb & Sons, L.L.C. | 12 | $256 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $200 |
| Amgen Inc. | 6 | $186 |
| PFIZER INC. | 12 | $183 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $160 |
| AstraZeneca Pharmaceuticals LP | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: Kerendia, CAMZYOS, Wegovy, ELIQUIS, JARDIANCE, Ozempic, LOKELMA, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
